Prognostic Value of Sympathetic Modulation in Patients With Heart Failure
NCT ID: NCT02047409
Last Updated: 2015-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
160 participants
OBSERVATIONAL
2013-10-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REDUCED FUNCTIONALITY AND KINESIOPHOBIA IN PATIENTS WITH HEART FAILURE: USE OF ALTERNATIVE THERAPEUTIC STRATEGIES
NCT07099495
Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure
NCT05572736
Transcutaneous Electrical Nerve Stimulation and Cardiac Sympathetic Overdrive in Heart Failure
NCT03354689
Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction
NCT02115230
Trajectory Changes of Coronary Sinus Lead Tip and Cardiac Resynchronization Therapy Outcome
NCT02340546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ischemic, hypertensive, or idiopathic etiology
* Left ventricular ejection fraction less than 40%
Exclusion Criteria
* Renal failure
* Diabetes mellitus type II
30 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
InCor Heart Institute
OTHER
Fundação de Amparo à Pesquisa do Estado de São Paulo
OTHER_GOV
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart Institute (InCor), University of Sao Paulo, School of Medicine.
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/07651-7
Identifier Type: OTHER
Identifier Source: secondary_id
2010/50048-1
Identifier Type: OTHER
Identifier Source: secondary_id
EDT-13001-PD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.